DOZA consultant answered all my questions
Wane na wstpie: w zachodnim wiecie farmaceutycznym BPC-157 nigdy nie przeszed przez Phase 3 trials (= due prby kliniczne przed zatwierdzeniem leku)
Unlike traditional nootropics that temporarily modulate neurotransmitters, Dihexa is designed to stimulate synaptogenesis the formation of new neural connections
It can form what we call a bezoar, or a fiber brick, in the gut, leading to painful bloating and gas
The phospholipids it contains, which resemble cell membranes, play a key role in protecting the active ingredients from the acidic environment of the stomach
Besonders beeindruckend sind die Ergebnisse in Ulkus- und Darmverletzungsmodellen, wo BPC-157 die Heilung merklich beschleunigt